Sand Hill Angels

VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. Its lead product, a first-in-class non-invasive eyedrop, aims to replace invasive injections for conditions like age-related macular degeneration and diabetic macular edema.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

Biotia, Inc. is a health technology company based in New York, founded in 2016. It specializes in developing software and laboratory technologies that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery and management. By providing tailored microbial surveillance, Biotia's innovative solutions enable clinicians and researchers to identify and mitigate pathogens effectively, thereby reducing hospital-acquired infections and improving patient outcomes. The company's technology empowers healthcare professionals to guide treatment decisions proactively, ultimately aiming to prevent illnesses before they occur.

Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Thread Robotics provides medical devices and services with a focus on fertility care. It was founded in 2020 and operates in Mountain View, California.

Nanochon is developing an implantable, 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth in joints, with a focus on knee damage. The device combines 3D printing and a novel nanomaterial to enable on-demand, cost-effective solutions intended to restore joint function and improve outcomes for young and active patients.

LifeWave is a medical device company based in Los Altos, California, established in 2000. The company specializes in developing non-invasive sensing technologies for prenatal and neonatal monitoring in both clinical and remote settings. Its flagship product, the FetalConnect system, is designed for intrapartum fetal monitoring. Additionally, LifeWave is dedicated to creating maternal monitoring solutions aimed at addressing postpartum hemorrhage. The company also focuses on remote guided care solutions for patients with heart failure.

Qnovia is a biotechnology company specializing in aerosol science. It develops innovative devices and formulations for safely delivering a wide range of pharmaceuticals and nicotine via inhalation. The company aims to enhance public health by creating efficient medical devices, responsibly sourcing materials, advocating for legislation, providing transparent product information, and promoting sensible oversight.

Thirty Madison is a digital health company specializing in personalized treatments for chronic conditions. It operates platforms like Keeps (hair loss), Cove (migraines), Picnic (allergies), Facet (skin conditions), and Nurx (sexual health). Founded in 2016, it aims to empower individuals with accessible, effective care tailored to their specific needs.

StrongArm Technologies, Inc. is a safety science company that specializes in developing data collection and assessment solutions aimed at enhancing the safety of industrial workers. The company offers a risk monitoring device that utilizes machine learning to analyze risks related to musculoskeletal injuries, along with the FUSE Risk Management Platform, a cloud-based IoT-enabled software that leverages motion-interpreting sensors for real-time monitoring and assessment. Additionally, StrongArm provides a posture feedback system designed to assist industrial workers with proper lifting mechanics and postural support. Founded in 2011 and headquartered in Brooklyn, New York, StrongArm Technologies focuses on improving workplace safety through innovative technology.

Based in Boston's biotech hub, Elucid improves cardiovascular diagnostic imaging via machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software for evaluating plaque vulnerability from a single CT scan to inform risk assessment and treatment selection.

SDIP Innovations develops bioresorbable bone implants that mimic the body's natural bone remodeling process. Their innovative devices are designed to heal fractured bones while gradually resorbing into the body, promoting tissue regeneration and reducing the need for additional surgeries.

BrightInsight operates a digital health platform tailored for biopharma and medtech companies. Founded in 2017 and headquartered in San Jose, California, the company provides an Internet of Things (IoT) solution designed to support the development, scaling, and maintenance of regulated digital health products and services. The BrightInsight platform captures, transmits, and analyzes data from various sources, including medical devices, combination products, applications, and digital therapeutics, all while adhering to security, privacy, and regulatory standards. This integrated approach enables clients to enhance patient adherence and engagement, accelerate market entry, and reduce implementation costs across diverse products and global markets.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company's flagship product, ClearUP Sinus Pain Relief, is a handheld device designed to provide temporary relief from sinus pain and congestion associated with conditions such as nasal allergies and chronic sinusitis. This clinically proven device utilizes ultra-low current electrical waves to activate the body’s natural healing mechanisms, offering an alternative to conventional pharmaceutical treatments. Tivic Health received FDA clearance for ClearUP on January 2, 2019, and began shipping the product in September 2019, marking a significant advancement in the field of bioelectronic medicine.

Alertive Healthcare is a digital health company focused on hypertension and chronic disease management. It partners with healthcare organizations to remotely monitor patients with high blood pressure and deliver clinical recommendations between visits. Its platform aggregates data from FDA-approved Bluetooth-enabled blood pressure devices, enabling care teams to monitor trends, interpret information, and make timely decisions. By streamlining communication among clinicians and patients, the company aims to shorten the time to blood pressure control and improve health outcomes.

Lambs designs and manufactures stylish, high-tech underwear for men, featuring advanced fabric technology that shields testicles and sperm from electromagnetic radiation emitted by smartphones and Wi-Fi devices.

Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.

Imprint Energy, Inc. is a developer of innovative zinc-based rechargeable battery technology, focusing on creating flexible and low-cost battery solutions for portable electronics. Founded in 2010 and based in Alameda, California, the company has introduced its ZincPoly battery technology, which overcomes traditional limitations of zinc-based batteries, thus facilitating the production of rechargeable options. Imprint Energy's batteries are designed for various applications, including mobile accessories, compact wireless devices, wearable technology, health and fitness monitoring, and medical devices. The company’s unique electrochemistry system allows for thin, flexible, and high-energy-density batteries, produced through a scalable, print-based manufacturing process. This technology aims to deliver lithium-like performance at lower costs while enhancing safety and eliminating form factor constraints, addressing the evolving energy needs of modern electronic devices.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Thirty Madison is a digital health company specializing in personalized treatments for chronic conditions. It operates platforms like Keeps (hair loss), Cove (migraines), Picnic (allergies), Facet (skin conditions), and Nurx (sexual health). Founded in 2016, it aims to empower individuals with accessible, effective care tailored to their specific needs.

Volumetric, Inc. is an advanced biomaterials and biofabrication company based in Houston, Texas, established in 2014. It specializes in developing a 3D bioprinting platform designed to create vascularized human tissue, which can be utilized in various applications such as life sciences, drug discovery, and medical devices. The company offers bioprinters and bioinks that aim to facilitate innovations in biomaterials, cancer research, and the potential replacement of human organs. By focusing on creating materials embedded with living cells, Volumetric is at the forefront of integrating cutting-edge technology into healthcare solutions.

EYSZ is a digital health software company based in Piedmont, California, founded in 2018. It specializes in detection algorithms that utilize oculometric and facial biometric data to reliably detect seizures and assist in the diagnosis and management of brain disorders, including epilepsy, ADHD, and depression. By employing machine learning techniques, EYSZ's software not only detects seizures but also predicts their occurrence. The platform is designed to interface and integrate with various eye-tracking systems, such as smart glasses, and therapeutic devices like neuromodulation tools, thereby enhancing the ability of clinicians to monitor and manage the neurological health of their patients effectively.

Fitnescity is a consumer health platform that partners with local labs to provide accessible health tests. It offers detailed protocols, comprehensive reports via analytics platform, and follow-up support to enhance users' wellness journey.

Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company's flagship product, ClearUP Sinus Pain Relief, is a handheld device designed to provide temporary relief from sinus pain and congestion associated with conditions such as nasal allergies and chronic sinusitis. This clinically proven device utilizes ultra-low current electrical waves to activate the body’s natural healing mechanisms, offering an alternative to conventional pharmaceutical treatments. Tivic Health received FDA clearance for ClearUP on January 2, 2019, and began shipping the product in September 2019, marking a significant advancement in the field of bioelectronic medicine.

Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Augmedix is a technology company that provides AI-powered medical documentation solutions for healthcare systems. Its platform converts natural clinician-patient conversations into real-time medical notes, organized data, and point-of-care notifications, which are transferred into electronic health records. The cloud-based system, complemented by remote medical scribes, reduces EHR documentation time and administrative burden, enabling clinicians to focus more on patient care. Augmedix serves hospitals and health systems, and has built partnerships across care settings. The company was founded in 2012 and is based in San Francisco, with offices in Menlo Park and Dhaka. The platform is available to clinicians via mobile apps and integrates ambient AI, data, and trusted workflows to improve clinical, operational, and financial outcomes.

Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.

Alertive Healthcare is a digital health company focused on hypertension and chronic disease management. It partners with healthcare organizations to remotely monitor patients with high blood pressure and deliver clinical recommendations between visits. Its platform aggregates data from FDA-approved Bluetooth-enabled blood pressure devices, enabling care teams to monitor trends, interpret information, and make timely decisions. By streamlining communication among clinicians and patients, the company aims to shorten the time to blood pressure control and improve health outcomes.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.

Volumetric, Inc. is an advanced biomaterials and biofabrication company based in Houston, Texas, established in 2014. It specializes in developing a 3D bioprinting platform designed to create vascularized human tissue, which can be utilized in various applications such as life sciences, drug discovery, and medical devices. The company offers bioprinters and bioinks that aim to facilitate innovations in biomaterials, cancer research, and the potential replacement of human organs. By focusing on creating materials embedded with living cells, Volumetric is at the forefront of integrating cutting-edge technology into healthcare solutions.

Augmedix is a technology company that provides AI-powered medical documentation solutions for healthcare systems. Its platform converts natural clinician-patient conversations into real-time medical notes, organized data, and point-of-care notifications, which are transferred into electronic health records. The cloud-based system, complemented by remote medical scribes, reduces EHR documentation time and administrative burden, enabling clinicians to focus more on patient care. Augmedix serves hospitals and health systems, and has built partnerships across care settings. The company was founded in 2012 and is based in San Francisco, with offices in Menlo Park and Dhaka. The platform is available to clinicians via mobile apps and integrates ambient AI, data, and trusted workflows to improve clinical, operational, and financial outcomes.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company's flagship product, ClearUP Sinus Pain Relief, is a handheld device designed to provide temporary relief from sinus pain and congestion associated with conditions such as nasal allergies and chronic sinusitis. This clinically proven device utilizes ultra-low current electrical waves to activate the body’s natural healing mechanisms, offering an alternative to conventional pharmaceutical treatments. Tivic Health received FDA clearance for ClearUP on January 2, 2019, and began shipping the product in September 2019, marking a significant advancement in the field of bioelectronic medicine.

Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.

Mindshare Medical, Inc. is a company that develops clinical decision support technology aimed at enhancing the capabilities of clinicians and healthcare organizations. Established in May 2014 and based in San Juan Capistrano, California, the company focuses on evidence-based solutions that provide diagnostics and guidance regarding the effectiveness of follow-up procedures and treatments. Its proprietary technology assists radiologists and specialists in improving the detection and characterization of diseases, including assessing severity and progression. By offering personalized insights, Mindshare Medical aims to improve the quality of patient care while also reducing financial liabilities for healthcare providers.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

StrongArm Technologies, Inc. is a safety science company that specializes in developing data collection and assessment solutions aimed at enhancing the safety of industrial workers. The company offers a risk monitoring device that utilizes machine learning to analyze risks related to musculoskeletal injuries, along with the FUSE Risk Management Platform, a cloud-based IoT-enabled software that leverages motion-interpreting sensors for real-time monitoring and assessment. Additionally, StrongArm provides a posture feedback system designed to assist industrial workers with proper lifting mechanics and postural support. Founded in 2011 and headquartered in Brooklyn, New York, StrongArm Technologies focuses on improving workplace safety through innovative technology.

LifeWave is a medical device company based in Los Altos, California, established in 2000. The company specializes in developing non-invasive sensing technologies for prenatal and neonatal monitoring in both clinical and remote settings. Its flagship product, the FetalConnect system, is designed for intrapartum fetal monitoring. Additionally, LifeWave is dedicated to creating maternal monitoring solutions aimed at addressing postpartum hemorrhage. The company also focuses on remote guided care solutions for patients with heart failure.

Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.

Mission Bio develops and delivers tools for studying cellular heterogeneity in human health and life science research. Its flagship product is the Tapestri Platform, a single-cell platform that detects DNA and protein changes, enabling precise detection of heterogeneity in disease progression and treatment response. The company's solutions are primarily applied in oncology, including blood cancers and solid tumors.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

InnoVein, Inc. is a medical device company established in 2015 and based in San Carlos, California. The company specializes in developing implantable valves designed to regulate blood flow in the veins, particularly for elderly patients suffering from venous insufficiency disease. InnoVein aims to address the challenges associated with this condition through innovative cardiac and arterial solutions, contributing to improved health outcomes for affected individuals.

Mission Bio develops and delivers tools for studying cellular heterogeneity in human health and life science research. Its flagship product is the Tapestri Platform, a single-cell platform that detects DNA and protein changes, enabling precise detection of heterogeneity in disease progression and treatment response. The company's solutions are primarily applied in oncology, including blood cancers and solid tumors.

Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.

Kenzen, Inc. is a health technology company that specializes in developing wearable solutions for health and performance monitoring. Its flagship product, the Kenzen ECHO, is a wireless smart patch designed to provide real-time monitoring of vital signs and physiological data, with a focus on preventing injuries related to heat stress, fatigue, and over-exertion in industrial settings. The ECHO system includes a mobile application that delivers personalized health insights and alerts, ensuring that workers and their supervisors can take proactive measures to enhance safety and productivity. Incorporated in 2014 and based in New York, Kenzen sells its products through various distributors, resellers, and retail locations, aiming to harness physiological data to improve workforce safety and well-being.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company's flagship product, ClearUP Sinus Pain Relief, is a handheld device designed to provide temporary relief from sinus pain and congestion associated with conditions such as nasal allergies and chronic sinusitis. This clinically proven device utilizes ultra-low current electrical waves to activate the body’s natural healing mechanisms, offering an alternative to conventional pharmaceutical treatments. Tivic Health received FDA clearance for ClearUP on January 2, 2019, and began shipping the product in September 2019, marking a significant advancement in the field of bioelectronic medicine.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. Founded in 2015 and headquartered in El Cerrito, California, the company focuses on providing diagnostic technology for the detection and monitoring of blood concentrations. This innovative approach allows healthcare professionals to make informed decisions regarding appropriate therapies for patients in critical care settings. ProbiusDx aims to enhance patient outcomes through its advanced diagnostic solutions.

TheraDep specializes in the development of advanced surface coatings for microneedles and labware, focusing on applications in the medical device and pharmaceutical sectors. The company offers biocompatible, drug-eluting, growth-promoting, and therapeutic coatings, utilizing a novel patented process. By collaborating with medical device and labware manufacturers, TheraDep provides customized solutions that address specific needs in drug delivery and patient treatment, enhancing the effectiveness and safety of medical applications.

Mission Bio develops and delivers tools for studying cellular heterogeneity in human health and life science research. Its flagship product is the Tapestri Platform, a single-cell platform that detects DNA and protein changes, enabling precise detection of heterogeneity in disease progression and treatment response. The company's solutions are primarily applied in oncology, including blood cancers and solid tumors.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company's flagship product, ClearUP Sinus Pain Relief, is a handheld device designed to provide temporary relief from sinus pain and congestion associated with conditions such as nasal allergies and chronic sinusitis. This clinically proven device utilizes ultra-low current electrical waves to activate the body’s natural healing mechanisms, offering an alternative to conventional pharmaceutical treatments. Tivic Health received FDA clearance for ClearUP on January 2, 2019, and began shipping the product in September 2019, marking a significant advancement in the field of bioelectronic medicine.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

TheraDep specializes in the development of advanced surface coatings for microneedles and labware, focusing on applications in the medical device and pharmaceutical sectors. The company offers biocompatible, drug-eluting, growth-promoting, and therapeutic coatings, utilizing a novel patented process. By collaborating with medical device and labware manufacturers, TheraDep provides customized solutions that address specific needs in drug delivery and patient treatment, enhancing the effectiveness and safety of medical applications.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

StrongArm Technologies, Inc. is a safety science company that specializes in developing data collection and assessment solutions aimed at enhancing the safety of industrial workers. The company offers a risk monitoring device that utilizes machine learning to analyze risks related to musculoskeletal injuries, along with the FUSE Risk Management Platform, a cloud-based IoT-enabled software that leverages motion-interpreting sensors for real-time monitoring and assessment. Additionally, StrongArm provides a posture feedback system designed to assist industrial workers with proper lifting mechanics and postural support. Founded in 2011 and headquartered in Brooklyn, New York, StrongArm Technologies focuses on improving workplace safety through innovative technology.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

Cadence Biomedical, Inc. is an early-stage medical device company based in Seattle, Washington, focused on restoring walking abilities for individuals with severe mobility impairments. The company's primary product, Kickstart, is a neurorehabilitation device designed to enhance recovery in patients suffering from conditions such as stroke, spinal cord injury, and multiple sclerosis. Utilizing innovative Exotendon technology, Kickstart mimics the function of an artificial tendon, providing necessary stability, support, and swing assistance. This device is utilized in both outpatient physical therapy and for home use, facilitating continued recovery post-discharge. Cadence Biomedical was originally established as Empowering Engineering Technologies, Corp. in 2007 and has since developed a new kinetic orthosis device, building on technology developed at the Cleveland Clinic by Dr. A.J. van den Bogert.

Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.

Mission Bio develops and delivers tools for studying cellular heterogeneity in human health and life science research. Its flagship product is the Tapestri Platform, a single-cell platform that detects DNA and protein changes, enabling precise detection of heterogeneity in disease progression and treatment response. The company's solutions are primarily applied in oncology, including blood cancers and solid tumors.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, that specializes in developing medical products and research tools focused on male fertility management. Founded in 2012, the company manufactures innovative devices such as the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a tool for remote blood sampling that facilitates comprehensive diagnostic testing. Additionally, Sandstone offers the Trak fertility system, which includes an engine, a disposable test plate, a sample collection cup, and a dropper, enabling men to monitor their sperm quality and take proactive steps toward improving their fertility. The accompanying Trak mobile application allows users to track their fertility data over time, identify potential fertility issues, and enhance their chances of conception. Sandstone Diagnostics aims to empower couples to manage their reproductive health in the comfort and privacy of their homes.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. The company focuses on innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. Its flagship product, RenovoCath, is an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to improve therapeutic outcomes, particularly for cancer patients, through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while reducing potential toxicities associated with systemic therapies. Supported by a team of experienced management and a diverse Advisory Board of medical professionals, RenovoRx is committed to advancing its clinical development strategies and addressing high unmet medical needs in cancer treatment.

Cadence Biomedical, Inc. is an early-stage medical device company based in Seattle, Washington, focused on restoring walking abilities for individuals with severe mobility impairments. The company's primary product, Kickstart, is a neurorehabilitation device designed to enhance recovery in patients suffering from conditions such as stroke, spinal cord injury, and multiple sclerosis. Utilizing innovative Exotendon technology, Kickstart mimics the function of an artificial tendon, providing necessary stability, support, and swing assistance. This device is utilized in both outpatient physical therapy and for home use, facilitating continued recovery post-discharge. Cadence Biomedical was originally established as Empowering Engineering Technologies, Corp. in 2007 and has since developed a new kinetic orthosis device, building on technology developed at the Cleveland Clinic by Dr. A.J. van den Bogert.

Catheter Connections, Inc. specializes in the development and commercialization of vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and headquartered in Salt Lake City, Utah, the company offers the DualCap System, a set of user-friendly disinfecting caps designed to protect against IV catheter-related bloodstream infections. This system includes various products such as the DualCap, which features distinct caps for IV line connectors and luer access valves, as well as DualCap Duo and DualCap Solo for specific capping needs. By providing these innovative solutions, Catheter Connections helps healthcare facilities enhance infection control practices during IV therapy. The company operates primarily through sales representatives and serves healthcare facilities across the United States. As of January 31, 2017, Catheter Connections is a subsidiary of Merit Medical Systems, Inc.

Figure 8 Surgical, Inc. is a medical device company based in Palo Alto, California, that specializes in developing surgical technologies. Founded in 2009, it focuses on innovations for cardiac surgery, particularly with its FDA-approved sternum repair device. This device is designed to replace traditional steel wire for primary sternal closure following open-heart surgery. It combines the simplicity of wire cerclage with advanced engineering features that provide superior multi-vector strength and ease of placement. By offering a more effective alternative to conventional methods, Figure 8 Surgical aims to reduce complications and improve surgical outcomes for patients undergoing heart surgery.

Catheter Connections, Inc. specializes in the development and commercialization of vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and headquartered in Salt Lake City, Utah, the company offers the DualCap System, a set of user-friendly disinfecting caps designed to protect against IV catheter-related bloodstream infections. This system includes various products such as the DualCap, which features distinct caps for IV line connectors and luer access valves, as well as DualCap Duo and DualCap Solo for specific capping needs. By providing these innovative solutions, Catheter Connections helps healthcare facilities enhance infection control practices during IV therapy. The company operates primarily through sales representatives and serves healthcare facilities across the United States. As of January 31, 2017, Catheter Connections is a subsidiary of Merit Medical Systems, Inc.

Cadence Biomedical, Inc. is an early-stage medical device company based in Seattle, Washington, focused on restoring walking abilities for individuals with severe mobility impairments. The company's primary product, Kickstart, is a neurorehabilitation device designed to enhance recovery in patients suffering from conditions such as stroke, spinal cord injury, and multiple sclerosis. Utilizing innovative Exotendon technology, Kickstart mimics the function of an artificial tendon, providing necessary stability, support, and swing assistance. This device is utilized in both outpatient physical therapy and for home use, facilitating continued recovery post-discharge. Cadence Biomedical was originally established as Empowering Engineering Technologies, Corp. in 2007 and has since developed a new kinetic orthosis device, building on technology developed at the Cleveland Clinic by Dr. A.J. van den Bogert.

Cadence Biomedical, Inc. is an early-stage medical device company based in Seattle, Washington, focused on restoring walking abilities for individuals with severe mobility impairments. The company's primary product, Kickstart, is a neurorehabilitation device designed to enhance recovery in patients suffering from conditions such as stroke, spinal cord injury, and multiple sclerosis. Utilizing innovative Exotendon technology, Kickstart mimics the function of an artificial tendon, providing necessary stability, support, and swing assistance. This device is utilized in both outpatient physical therapy and for home use, facilitating continued recovery post-discharge. Cadence Biomedical was originally established as Empowering Engineering Technologies, Corp. in 2007 and has since developed a new kinetic orthosis device, building on technology developed at the Cleveland Clinic by Dr. A.J. van den Bogert.

Figure 8 Surgical, Inc. is a medical device company based in Palo Alto, California, that specializes in developing surgical technologies. Founded in 2009, it focuses on innovations for cardiac surgery, particularly with its FDA-approved sternum repair device. This device is designed to replace traditional steel wire for primary sternal closure following open-heart surgery. It combines the simplicity of wire cerclage with advanced engineering features that provide superior multi-vector strength and ease of placement. By offering a more effective alternative to conventional methods, Figure 8 Surgical aims to reduce complications and improve surgical outcomes for patients undergoing heart surgery.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

OncoHealth is a company that specializes in the development of screening devices aimed at detecting and diagnosing cancer. Its innovative technology focuses on the creation of protein bio-markers specifically for the screening and diagnostics of cervical cancer and other cancers associated with the human papillomavirus (HPV). By providing advanced tools for medical professionals, OncoHealth enhances the ability to monitor, diagnose, and treat cancer, ultimately contributing to improved patient outcomes in oncology.

Niveus Medical, Inc. is a healthcare company that specializes in developing muscle stimulation systems aimed at preventing muscle atrophy, particularly in the quadriceps. Founded in 2008 and located in Palo Alto, California, Niveus Medical focuses on providing effective stimulation to key muscle groups during periods of sedation and bed rest, such as in intensive care unit (ICU) settings. The company's technology enhances local blood circulation and is indicated for maintaining or increasing the range of motion of the knee joint. Its systems are designed to facilitate muscle re-education, prevent disuse atrophy, and alleviate muscle spasms, ultimately promoting faster recovery for patients and increasing the likelihood of successful treatment outcomes. The company operates under the brand IntelliSTIM.

Catheter Connections, Inc. specializes in the development and commercialization of vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and headquartered in Salt Lake City, Utah, the company offers the DualCap System, a set of user-friendly disinfecting caps designed to protect against IV catheter-related bloodstream infections. This system includes various products such as the DualCap, which features distinct caps for IV line connectors and luer access valves, as well as DualCap Duo and DualCap Solo for specific capping needs. By providing these innovative solutions, Catheter Connections helps healthcare facilities enhance infection control practices during IV therapy. The company operates primarily through sales representatives and serves healthcare facilities across the United States. As of January 31, 2017, Catheter Connections is a subsidiary of Merit Medical Systems, Inc.

Figure 8 Surgical, Inc. is a medical device company based in Palo Alto, California, that specializes in developing surgical technologies. Founded in 2009, it focuses on innovations for cardiac surgery, particularly with its FDA-approved sternum repair device. This device is designed to replace traditional steel wire for primary sternal closure following open-heart surgery. It combines the simplicity of wire cerclage with advanced engineering features that provide superior multi-vector strength and ease of placement. By offering a more effective alternative to conventional methods, Figure 8 Surgical aims to reduce complications and improve surgical outcomes for patients undergoing heart surgery.

OncoHealth is a company that specializes in the development of screening devices aimed at detecting and diagnosing cancer. Its innovative technology focuses on the creation of protein bio-markers specifically for the screening and diagnostics of cervical cancer and other cancers associated with the human papillomavirus (HPV). By providing advanced tools for medical professionals, OncoHealth enhances the ability to monitor, diagnose, and treat cancer, ultimately contributing to improved patient outcomes in oncology.

Cadence Biomedical, Inc. is an early-stage medical device company based in Seattle, Washington, focused on restoring walking abilities for individuals with severe mobility impairments. The company's primary product, Kickstart, is a neurorehabilitation device designed to enhance recovery in patients suffering from conditions such as stroke, spinal cord injury, and multiple sclerosis. Utilizing innovative Exotendon technology, Kickstart mimics the function of an artificial tendon, providing necessary stability, support, and swing assistance. This device is utilized in both outpatient physical therapy and for home use, facilitating continued recovery post-discharge. Cadence Biomedical was originally established as Empowering Engineering Technologies, Corp. in 2007 and has since developed a new kinetic orthosis device, building on technology developed at the Cleveland Clinic by Dr. A.J. van den Bogert.

Catheter Connections, Inc. specializes in the development and commercialization of vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and headquartered in Salt Lake City, Utah, the company offers the DualCap System, a set of user-friendly disinfecting caps designed to protect against IV catheter-related bloodstream infections. This system includes various products such as the DualCap, which features distinct caps for IV line connectors and luer access valves, as well as DualCap Duo and DualCap Solo for specific capping needs. By providing these innovative solutions, Catheter Connections helps healthcare facilities enhance infection control practices during IV therapy. The company operates primarily through sales representatives and serves healthcare facilities across the United States. As of January 31, 2017, Catheter Connections is a subsidiary of Merit Medical Systems, Inc.

OncoHealth is a company that specializes in the development of screening devices aimed at detecting and diagnosing cancer. Its innovative technology focuses on the creation of protein bio-markers specifically for the screening and diagnostics of cervical cancer and other cancers associated with the human papillomavirus (HPV). By providing advanced tools for medical professionals, OncoHealth enhances the ability to monitor, diagnose, and treat cancer, ultimately contributing to improved patient outcomes in oncology.

Figure 8 Surgical, Inc. is a medical device company based in Palo Alto, California, that specializes in developing surgical technologies. Founded in 2009, it focuses on innovations for cardiac surgery, particularly with its FDA-approved sternum repair device. This device is designed to replace traditional steel wire for primary sternal closure following open-heart surgery. It combines the simplicity of wire cerclage with advanced engineering features that provide superior multi-vector strength and ease of placement. By offering a more effective alternative to conventional methods, Figure 8 Surgical aims to reduce complications and improve surgical outcomes for patients undergoing heart surgery.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

Catheter Connections, Inc. specializes in the development and commercialization of vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and headquartered in Salt Lake City, Utah, the company offers the DualCap System, a set of user-friendly disinfecting caps designed to protect against IV catheter-related bloodstream infections. This system includes various products such as the DualCap, which features distinct caps for IV line connectors and luer access valves, as well as DualCap Duo and DualCap Solo for specific capping needs. By providing these innovative solutions, Catheter Connections helps healthcare facilities enhance infection control practices during IV therapy. The company operates primarily through sales representatives and serves healthcare facilities across the United States. As of January 31, 2017, Catheter Connections is a subsidiary of Merit Medical Systems, Inc.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

Vaxart is a clinical-stage biotechnology company developing oral recombinant protein vaccines using its proprietary platform. Its pipeline includes vaccines for norovirus, influenza, RSV, and HPV, with products administered via convenient room-temperature stable tablets.

IMI Intelligent Medical Implants develops and markets intelligent retinal implant systems for degenerative retinal disorders. The company offers The Intelligent Retinal Implant System, an adaptive visual prosthesis that bridges and replaces the defective information processing function of the real retina in patients with retinal degeneration. IMI Intelligent Medical Implants was founded in 2002 and is based in Zug, Switzerland.